24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
FSD Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:51
Zenity: “The disruption is real, but so is the potential”
10:48
From unicorns to rollups: How VC became PE
10:02
NSO seeks new trial after $168 million jury verdict in WhatsApp case
09:33
Noam Mills faced the world’s best in fencing. Now she’s solving a problem most CFOs ignore
More stories
Buzz
Most popular
Daily
Weekly
1
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
2
Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security
3
Guardicore founders raise $32 million for new stealth cyber-AI startup
4
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
5
Syte files for court protection after burning through $70 million in funding
More news
FSD Pharma
3 stories about FSD Pharma
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock
23.10.18
|
Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
